Cancer biomarker research using complementary NGS technologies

Maximize ability to confidently identify and confirm biomarkers in germline and somatic mutations

You should have confidence in your technology when it comes to characterizing biomarkers in germline or somatic mutations. We’ve developed two high-performing targeted NGS approaches to give you that confidence.

In this app note we describe a supplemental study to a previously published note [1] that uses both the IDT xGen™ Prism Library Kit and Lockdown™ Probe system for target capture, and the rhAmpSeq™ Amplicon Sequencing System. Both approaches showed sensitivity down to 1% VAF in cfDNA samples starting from low quantities of DNA input.